Anti–Glutamic Acid Decarboxylase Antibodies in the Serum and Cerebrospinal Fluid of Patients With Stiff-Person Syndrome

Archives of Neurology
doi 10.1001/archneur.61.6.902
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Cerebellar Ataxia With Anti–Glutamic Acid Decarboxylase Antibodies

Archives of Neurology
2001English

Diabetes Mellitus and Ataxia With Anti-Glutamic Acid Decarboxylase Antibodies

Endocrine Abstracts
2016English

Epilepsy and Cerebellar Ataxia Associated With Anti-Glutamic Acid Decarboxylase Antibodies

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2007English

Effects of Anti-Glutamic Acid Decarboxylase Antibodies Associated With Neurological Diseases

Annals of Neurology
Neurology
2007English

Anti-Gad Antibodies and Breast Cancer in a Patient With Stiff-Person Syndrome: A Puzzling Association

European Neurology
Neurology
2001English

Identification of a Dominant Epitope of Glutamic Acid Decarboxylase (GAD-65) Recognized by Autoantibodies in Stiff-Man Syndrome

Journal of Experimental Medicine
MedicineAllergyImmunology
1993English

Cerebellar Ataxia Associated With Glutamic Acid Decarboxylase Autoantibody (Anti GAD)

Scholars Journal of Medical Case Reports
2020English

Cerebrospinal Fluid and Serum Uric Acid Levels in Patients With Multiple Sclerosis

Clinical Chemistry and Laboratory Medicine
BiochemistryMedicineClinical Biochemistry
2009English

Absence of Glutamic Acid Decarboxylase Antibodies in Pima Indian Children With Diabetes Mellitus

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy